1. Home
  2. BFC vs RAPP Comparison

BFC vs RAPP Comparison

Compare BFC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$142.17

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$39.17

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
RAPP
Founded
1894
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
BFC
RAPP
Price
$142.17
$39.17
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$150.00
$48.50
AVG Volume (30 Days)
64.9K
252.4K
Earning Date
04-17-2026
05-07-2026
Dividend Yield
1.40%
N/A
EPS Growth
11.23
24.34
EPS
7.23
N/A
Revenue
N/A
N/A
Revenue This Year
$58.67
N/A
Revenue Next Year
$2.01
N/A
P/E Ratio
$19.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$105.24
$7.73
52 Week High
$153.00
$42.27

Technical Indicators

Market Signals
Indicator
BFC
RAPP
Relative Strength Index (RSI) 59.44 78.71
Support Level $118.71 $25.48
Resistance Level $145.74 $42.27
Average True Range (ATR) 3.06 2.04
MACD 0.81 0.71
Stochastic Oscillator 74.52 97.65

Price Performance

Historical Comparison
BFC
RAPP

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: